{"DataElement":{"publicId":"14634419","version":"1","preferredName":"Concomitant Medication Administered Reason","preferredDefinition":"The reason a concomitant medication was administered.","longName":"CM_ADM_RSN","context":"CCTG","contextVersion":"1","DataElementConcept":{"publicId":"2195361","version":"1","preferredName":"Concomitant Medication Administered","preferredDefinition":"information related to the concomitant medication administered.","longName":"CONCOM_MEDS_ADM","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206481","version":"1","preferredName":"Concomitant Medication","preferredDefinition":"Concomitant; following as a consequence.:biologically active substance, including those intended for use in diagnosis, treatment, or prevention of disease or other abnormalities, for the relief of suffering, or control or improvement of a physical or mental state; includes biological products.","longName":"C25730:C459","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Concomitant","conceptCode":"C25730","definition":"Accessory, accompanying especially in a subordinate or incidental way, occurring or existing during the same period of time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Medication","conceptCode":"C459","definition":"A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-F6E6-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177665","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"Administered","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-516D-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED56CEE5-E520-67E4-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-01-10","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"14634418","version":"1","preferredName":"Concomitant Agent Reason","preferredDefinition":"A pharmaceutical agent other than agent(s) tested in a given protocol that is administered to or used by a subject either prior to or during the study. Supportive care and essential ancillary medications required by a treatment regimen should be clearly identified. A protocol's complete instructions including appropriate indication, dosage, administration route, schedule, restrictions to use, and any other relevant data should be explicitly stated. Concept also refers to substance(s) used prior or during the study that are not specified by the protocol._An explanation of the cause of some phenomenon or action.","longName":"14634418v1.00","context":"CCTG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Oral pain","valueDescription":null,"ValueMeaning":{"publicId":"2945849","version":"1","preferredName":"Oral Pain","longName":"2945849","preferredDefinition":"Painful sensation in the mouth, tongue, or lips.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oral Pain","conceptCode":"C78509","definition":"Painful sensation in the mouth, tongue, or lips.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74597246-1661-6D19-E040-BB89AD431E08","latestVersionIndicator":"Yes","beginDate":"2009-09-24","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ECEA-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Osteoporosis","valueDescription":null,"ValueMeaning":{"publicId":"2945846","version":"1","preferredName":"Osteoporosis","longName":"2945846","preferredDefinition":"A condition of reduced bone mass, with decreased cortical thickness and a decrease in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence. Osteoporosis is classified as primary (Type 1, postmenopausal osteoporosis; Type 2, age-associated osteoporosis; and idiopathic, which can affect juveniles, premenopausal women, and middle-aged men) and secondary osteoporosis (which results from an identifiable cause of bone mass loss).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Osteoporosis","conceptCode":"C3298","definition":"A condition of reduced bone mass, with decreased cortical thickness and a decrease in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence. Osteoporosis is classified as primary (Type 1, postmenopausal osteoporosis; Type 2, age-associated osteoporosis; and idiopathic, which can affect juveniles, premenopausal women, and middle-aged men) and secondary osteoporosis (which results from an identifiable cause of bone mass loss).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74597246-1619-6D19-E040-BB89AD431E08","latestVersionIndicator":"Yes","beginDate":"2009-09-24","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ECEB-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Pain in extremity","valueDescription":null,"ValueMeaning":{"publicId":"14634850","version":"1","preferredName":"Limb Pain","longName":"14634850v1.00","preferredDefinition":"Painful sensation in the upper or lower extremities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Limb Pain","conceptCode":"C187370","definition":"Painful sensation in the upper or lower extremities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECC8-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ECEC-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Palmar-plantar erythrodysesthesia/hand-foot syndrome","valueDescription":null,"ValueMeaning":{"publicId":"2946004","version":"1","preferredName":"Palmar-Plantar Erythodysthesia","longName":"2946004","preferredDefinition":"A condition characterized by redness, pain, swelling, and tingling in the palms of the hands or the soles of the feet. It may appear as a side effect to chemotherapy agents.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Palmar-Plantar Erythrodysthesia","conceptCode":"C27177","definition":"A condition characterized by redness, pain, swelling, and tingling in the palms of the hands or the soles of the feet. It may appear as a side effect to chemotherapy agents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746944AF-4216-DCDB-E040-BB89AD437B02","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ECED-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Palpitations","valueDescription":null,"ValueMeaning":{"publicId":"2945899","version":"1","preferredName":"Palpitation","longName":"2945899","preferredDefinition":"Palpitations; unpleasant sensation of irregular and/or forceful beating of the heart.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Palpitation","conceptCode":"C37999","definition":"An unpleasant sensation of irregular and/or forceful beating of the heart.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74597246-1A5A-6D19-E040-BB89AD431E08","latestVersionIndicator":"Yes","beginDate":"2009-09-24","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ECEE-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Pancreatitis","valueDescription":null,"ValueMeaning":{"publicId":"2946003","version":"1","preferredName":"Pancreatitis","longName":"2946003","preferredDefinition":"Inflammation of the pancreas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatitis","conceptCode":"C3306","definition":"Inflammation of the pancreas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746944AF-41F3-DCDB-E040-BB89AD437B02","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ECEF-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Pelvic pain","valueDescription":null,"ValueMeaning":{"publicId":"2945872","version":"1","preferredName":"Pelvic Pain","longName":"2945872","preferredDefinition":"Painful sensation in the pelvis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pelvic Pain","conceptCode":"C40122","definition":"Painful sensation in the pelvis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74597246-184A-6D19-E040-BB89AD431E08","latestVersionIndicator":"Yes","beginDate":"2009-09-24","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ECF0-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Platelets/thrombocytopenia","valueDescription":null,"ValueMeaning":{"publicId":"14634851","version":"1","preferredName":"Platelet Or Thrombocytopenia","longName":"14634851v1.00","preferredDefinition":"An irregular, disc-shaped element in the blood that assists in blood clotting. Platelets are not blood cells, they are fragments of large bone marrow cells called megakaryocytes._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A laboratory test result indicating that there is an abnormally small number of platelets in the circulating blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Platelet","conceptCode":"C12520","definition":"An irregular, disc-shaped element in the blood that assists in blood clotting. Platelets are not blood cells, they are fragments of large bone marrow cells called megakaryocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Thrombocytopenia","conceptCode":"C3408","definition":"A laboratory test result indicating that there is an abnormally small number of platelets in the circulating blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECC9-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ECF1-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Pneumonitis","valueDescription":null,"ValueMeaning":{"publicId":"7318722","version":"1","preferredName":"Pneumonitis","longName":"7318722","preferredDefinition":"An inflammatory process affecting the lung parenchyma. It is a milder form of lung inflammation compared to pneumonia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pneumonitis","conceptCode":"C113159","definition":"An inflammatory process affecting the lung parenchyma. It is a milder form of lung inflammation compared to pneumonia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A757D580-B7B9-26D7-E053-4EBD850A4DBD","latestVersionIndicator":"Yes","beginDate":"2020-06-05","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2020-06-05","modifiedBy":"ONEDATA","dateModified":"2020-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ECF2-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Pre-treatment prophylaxis","valueDescription":null,"ValueMeaning":{"publicId":"14634852","version":"1","preferredName":"Pre-Therapy Preventive Intervention","longName":"14634852v1.00","preferredDefinition":"Occurring before a therapeutic procedure._Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pre-Therapy","conceptCode":"C54734","definition":"Occurring before a therapeutic procedure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Preventive Intervention","conceptCode":"C15843","definition":"Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECCA-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ECF3-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Pruritus","valueDescription":null,"ValueMeaning":{"publicId":"2757871","version":"1","preferredName":"Pruritus","longName":"2757871","preferredDefinition":"An intense itching sensation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pruritus","conceptCode":"C3344","definition":"An intense itching sensation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D43A-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ECF4-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Rash","valueDescription":null,"ValueMeaning":{"publicId":"2578055","version":"1","preferredName":"Skin Rash","longName":"2578055","preferredDefinition":"Any change in the skin which affects its appearance or texture. A rash may be localized to one part of the body, or affect all the skin. Rashes may cause the skin to change color, itch, become warm, bumpy, dry, cracked or blistered, swell and may be painful.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin Rash","conceptCode":"C39594","definition":"Any change in the skin which affects its appearance or texture. A rash may be localized to one part of the body, or affect all the skin. Rashes may cause the skin to change color, itch, become warm, bumpy, dry, cracked or blistered, swell and may be painful.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDF4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-01","modifiedBy":"COOPERM","dateModified":"2017-01-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ECF5-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Abdominal distension","valueDescription":null,"ValueMeaning":{"publicId":"2943950","version":"1","preferredName":"Abdominal Distention","longName":"2943950","preferredDefinition":"Swelling of the abdomen resulting from excessive food intake, malnutrition, liver disease, primary abdominal tumors, and tumors metastatic to the abdominal cavity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Abdominal Distension","conceptCode":"C78161","definition":"Swelling of the abdomen resulting from excessive food intake, malnutrition, liver disease, primary abdominal tumors, and tumors metastatic to the abdominal cavity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"742CB3BE-B823-F51E-E040-BB89AD432000","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ECF6-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Rectal pain","valueDescription":null,"ValueMeaning":{"publicId":"2946111","version":"1","preferredName":"Rectal Pain","longName":"2946111","preferredDefinition":"Pain in the rectal area.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rectal Pain","conceptCode":"C78587","definition":"Pain in the rectal area.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746AE5AE-68CE-370C-E040-BB89AD4351E3","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ECF7-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Acne","valueDescription":null,"ValueMeaning":{"publicId":"3055811","version":"1","preferredName":"Acne","longName":"3055811","preferredDefinition":"A disorder of the skin marked by inflammation of oil glands and hair glands.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acne","conceptCode":"C27195","definition":"An inflammatory process of the sebaceous glands which is characterized by comedones, nodules, papules and/or pustules on the skin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"83AA5DE5-186C-08BE-E040-BB89AD436888","latestVersionIndicator":"Yes","beginDate":"2010-04-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ECF8-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Rhinitis infective","valueDescription":null,"ValueMeaning":{"publicId":"2944673","version":"1","preferredName":"Infectious Rhinitis","longName":"2944673","preferredDefinition":"An inflammatory process affecting the nasal mucosa, usually caused by viruses (e.g., rhinovirus, adenovirus, parainfluenza virus, and coronavirus). It is characterized by chills, headaches, mucopurulent nasal discharge, coughing, and facial pain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infectious Rhinitis","conceptCode":"C78599","definition":"An inflammatory process affecting the nasal mucosa, usually caused by viruses (e.g., rhinovirus, adenovirus, parainfluenza virus, and coronavirus). It is characterized by chills, headaches, mucopurulent nasal discharge, coughing, and facial pain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7441B58E-C9B1-2969-E040-BB89AD430C38","latestVersionIndicator":"Yes","beginDate":"2009-09-23","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ECF9-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Agitation","valueDescription":null,"ValueMeaning":{"publicId":"2943961","version":"1","preferredName":"Agitation","longName":"2943961","preferredDefinition":"A state of restlessness associated with unpleasant feelings of irritability and tension. Causes include pain, stress, fever, alcohol and nicotine withdrawal, cocaine and hallucinogenic drugs use, depression, bipolar disorders, and schizophrenia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Agitation","conceptCode":"C79530","definition":"A state of restlessness associated with unpleasant feelings of irritability and tension. Causes include pain, stress, fever, alcohol and nicotine withdrawal, cocaine and hallucinogenic drugs use, depression, bipolar disorders, and schizophrenia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"742CB3BE-B939-F51E-E040-BB89AD432000","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ECFA-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Sedation","valueDescription":null,"ValueMeaning":{"publicId":"2751396","version":"1","preferredName":"Sedation","longName":"2751396","preferredDefinition":"The process of allaying nervous excitement or the state of being calmed. (Taber's)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sedation","conceptCode":"C21097","definition":"The process of allaying nervous excitement or the state of being calmed. (Taber's)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-09BC-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ECFB-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Allergic reaction/hypersensitivty","valueDescription":null,"ValueMeaning":{"publicId":"2944512","version":"1","preferredName":"Allergies","longName":"2944512","preferredDefinition":"An immune response that occurs following exposure to an innocuous antigen, but that does not require the presence of preformed antibodies to the antigen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypersensitivity","conceptCode":"C3114","definition":"An immune response that occurs following exposure to an innocuous antigen, but that does not require the presence of preformed antibodies to the antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"743C896C-2006-79F1-E040-BB89AD4359CF","latestVersionIndicator":"Yes","beginDate":"2009-09-23","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ECFC-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Seizure","valueDescription":null,"ValueMeaning":{"publicId":"5026016","version":"1","preferredName":"Seizure","longName":"5026016","preferredDefinition":"Sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Seizure","conceptCode":"C2962","definition":"Sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"20D2C91D-B832-E866-E050-BB89AD433C74","latestVersionIndicator":"Yes","beginDate":"2015-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-09-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ECFD-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Sensory neuropathy","valueDescription":null,"ValueMeaning":{"publicId":"2946018","version":"1","preferredName":"Peripheral Sensory Neuropathy","longName":"2946018","preferredDefinition":"functional disturbance or pathological change in the peripheral nervous system; sometimes limited to noninflammatory lesions as opposed to those of neuritis; etiology may be known or unknown.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Peripheral Sensory Neuropathy","conceptCode":"C3501","definition":"Inflammation or degeneration of the sensory nerves.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746944AF-4382-DCDB-E040-BB89AD437B02","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ECFE-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Allergy prophylaxis/seasonal allergy","valueDescription":null,"ValueMeaning":{"publicId":"14634853","version":"1","preferredName":"Allergic Reaction Preventive Intervention Or Seasonal Allergic Rhinitis","longName":"14634853v1.00","preferredDefinition":"An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures._Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Allergic rhinitis caused by outdoor allergens.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Allergic Reaction","conceptCode":"C114476","definition":"An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Preventive Intervention","conceptCode":"C15843","definition":"Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Seasonal Allergic Rhinitis","conceptCode":"C92188","definition":"Allergic rhinitis caused by outdoor allergens.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECCB-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ECFF-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Sleep aid","valueDescription":null,"ValueMeaning":{"publicId":"14634854","version":"1","preferredName":"Sleep Assistance","longName":"14634854v1.00","preferredDefinition":"A natural and periodic state of rest during which consciousness of the world is suspended._The act of contributing to the fulfillment of a need or furtherance of an effort.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sleep","conceptCode":"C73425","definition":"A natural and periodic state of rest during which consciousness of the world is suspended.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assistance","conceptCode":"C89271","definition":"The act of contributing to the fulfillment of a need or furtherance of an effort.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECCC-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED00-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Alopecia","valueDescription":null,"ValueMeaning":{"publicId":"2946575","version":"1","preferredName":"Alopecia","longName":"2946575","preferredDefinition":"Hair loss usually from the scalp. It may result in bald spots or spread to the entire scalp or the entire epidermis. It may be androgenetic or caused by chemotherapeutic agents, compulsive hair pulling, autoimmune disorders or congenital conditions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alopecia","conceptCode":"C50575","definition":"Hair loss usually from the scalp. It may result in bald spots or spread to the entire scalp or the entire epidermis. It may be androgenetic or caused by chemotherapeutic agents, compulsive hair pulling, autoimmune disorders or congenital conditions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74A54D4F-9F68-0EDF-E040-BB89AD430BAB","latestVersionIndicator":"Yes","beginDate":"2009-09-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-09-28","modifiedBy":"COOPERM","dateModified":"2020-04-16","changeDescription":"Updated definition to current NCIt. mc 4/16/20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED01-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Sore throat","valueDescription":null,"ValueMeaning":{"publicId":"2944607","version":"1","preferredName":"Sore Throat","longName":"2944607","preferredDefinition":"Any kind of inflammatory process of the tonsils, pharynx, or/and larynx characterized by pain in swallowing.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sore Throat","conceptCode":"C50747","definition":"Any kind of inflammatory process of the tonsils, pharynx, or/and larynx characterized by pain in swallowing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"743D5322-D1F5-677A-E040-BB89AD434340","latestVersionIndicator":"Yes","beginDate":"2009-09-23","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED02-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Alternative therapy","valueDescription":null,"ValueMeaning":{"publicId":"4163033","version":"1","preferredName":"Complementary and Alternate medicine","longName":"4163033","preferredDefinition":"Forms of treatment that are used in addition to (complementary) or instead of (alternative) standard treatments. These practices generally are not considered standard medical approaches. Standard treatments go through a long and careful research process to prove they are safe and effective, but less is known about most types of CAM. CAM may include dietary supplements, megadose vitamins, herbal preparations, special teas, acupuncture, massage therapy, magnet therapy, spiritual healing, and meditation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complementary and Alternative Medicine","conceptCode":"C15178","definition":"A group of diverse medical and health care systems, practices, and products that are not presently considered to be part of conventional medicine. Complementary medicine as being used together with conventional medicine, whereas alternative medicine is used in place of conventional medicine. The National Center for Complementary and Alternative Medicine (NCCAM) groups CAM practices into four domains, recognizing there can be some overlap: mind-body medicine; biologically based practices, manipulative and body-based practices, and energy medicine. In addition, NCCAM studies CAM whole medical systems, which cut across all domains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F2B66760-38BB-D9B8-E040-BB89AD435A64","latestVersionIndicator":"Yes","beginDate":"2014-02-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-02-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED03-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Stomach pain","valueDescription":null,"ValueMeaning":{"publicId":"2944580","version":"1","preferredName":"Stomach Pain","longName":"2944580","preferredDefinition":"A painful sensation in the stomach.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stomach Pain","conceptCode":"C78630","definition":"A painful sensation in the stomach.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"743D5322-CFD8-677A-E040-BB89AD434340","latestVersionIndicator":"Yes","beginDate":"2009-09-23","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED04-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Supplement","valueDescription":null,"ValueMeaning":{"publicId":"2757883","version":"1","preferredName":"Supplement","longName":"2757883","preferredDefinition":"Something added to complete a thing, make up for a deficiency, or extend or strengthen the whole; serving to complete or make an addition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Supplement","conceptCode":"C68641","definition":"Something added to complete a thing, make up for a deficiency, or extend or strengthen the whole; serving to complete or make an addition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D5D3-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED05-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Androgen suppression/LHRH agonist","valueDescription":null,"ValueMeaning":{"publicId":"14634855","version":"1","preferredName":"Androgen Suppression Or Gonadotropin-releasing Hormone Analog","longName":"14634855v1.00","preferredDefinition":"Blockage of the production of male hormones._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A synthetic analogue of the endogenous hormone gonadotropin-releasing hormone (GnRH), with potential antineoplastic activity. Upon administration, GnRH analogue mimics endogenous GnRH and strongly binds to and activates pituitary GnRH receptors, which stimulates the synthesis and secretion of the gonadotropic hormones, follicle stimulating hormone (FSH) and luteinizing hormone (LH). Continuous, prolonged activation by the GnRH analogue results in pituitary GnRH receptor desensitization and receptor downregulation. This causes inhibition of pituitary gonadotropin secretion of LH and FSH. In males, the inhibition of LH secretion prevents the production and release of testosterone from Leydig cells in the testes and causes a significant decline in testosterone production that is near the levels seen after castration. This may inhibit androgen receptor-positive tumor progression. In females, this results in a decrease in estradiol production. GnRH, also called luteinizing hormone-releasing hormone (LH-RH), is normally synthesized in and secreted by the hypothalamus. Synthetic analogues of GnRH have a stronger receptor binding affinity than the endogenous form.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Androgen Suppression","conceptCode":"C15676","definition":"Blockage of the production of male hormones.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Gonadotropin-releasing Hormone Analog","conceptCode":"C1910","definition":"A synthetic analogue of the endogenous hormone gonadotropin-releasing hormone (GnRH), with potential antineoplastic activity. Upon administration, GnRH analogue mimics endogenous GnRH and strongly binds to and activates pituitary GnRH receptors, which stimulates the synthesis and secretion of the gonadotropic hormones, follicle stimulating hormone (FSH) and luteinizing hormone (LH). Continuous, prolonged activation by the GnRH analogue results in pituitary GnRH receptor desensitization and receptor downregulation. This causes inhibition of pituitary gonadotropin secretion of LH and FSH. In males, the inhibition of LH secretion prevents the production and release of testosterone from Leydig cells in the testes and causes a significant decline in testosterone production that is near the levels seen after castration. This may inhibit androgen receptor-positive tumor progression. In females, this results in a decrease in estradiol production. GnRH, also called luteinizing hormone-releasing hormone (LH-RH), is normally synthesized in and secreted by the hypothalamus. Synthetic analogues of GnRH have a stronger receptor binding affinity than the endogenous form.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECCD-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED06-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Supraventricular arrhythmia","valueDescription":null,"ValueMeaning":{"publicId":"6407016","version":"1","preferredName":"Supraventricular Arrhythmia ECG Assessment","longName":"6407016","preferredDefinition":"An electrocardiographic assessment of the atypical cardiac rhythms originating in the atrium, AV node or AV junction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Supraventricular Arrhythmia ECG Assessment","conceptCode":"C111320","definition":"An electrocardiographic assessment of the atypical cardiac rhythms originating in the atrium, AV node or AV junction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73EBE24E-A81F-6916-E053-F662850A639B","latestVersionIndicator":"Yes","beginDate":"2018-08-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-08-21","modifiedBy":"ONEDATA","dateModified":"2018-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED07-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Sweating","valueDescription":null,"ValueMeaning":{"publicId":"4395670","version":"1","preferredName":"Sweating","longName":"4395670","preferredDefinition":"A watery secretion by the sweat glands that is primarily composed of salt, urea and minerals.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sweating","conceptCode":"C36172","definition":"A watery secretion by the sweat glands that is primarily composed of salt, urea and minerals.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB79BBE-6E76-5F7C-E040-BB89AD435DD5","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED08-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Anemia/hemoglobin","valueDescription":null,"ValueMeaning":{"publicId":"14634856","version":"1","preferredName":"Anemia Or Hemoglobin","longName":"14634856v1.00","preferredDefinition":"A reduction in the number of red blood cells, the amount of hemoglobin, and/or the volume of packed red blood cells. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._The red respiratory protein of erythrocytes, consisting of approximately 3.8% heme and 96.2% globin (64.5 KD), which as oxyhemoglobin (HbO2) transports oxygen from the lungs to the tissues where the oxygen is readily released and HbO2 becomes Hb.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anemia","conceptCode":"C2869","definition":"A reduction in the number of red blood cells, the amount of hemoglobin, and/or the volume of packed red blood cells. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hemoglobin","conceptCode":"C16676","definition":"The red respiratory protein of erythrocytes, consisting of approximately 3.8% heme and 96.2% globin (64.5 KD), which as oxyhemoglobin (HbO2) transports oxygen from the lungs to the tissues where the oxygen is readily released and HbO2 becomes Hb.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECCE-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED09-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Thrombosis/thrombus/embolism","valueDescription":null,"ValueMeaning":{"publicId":"14634857","version":"1","preferredName":"Thrombosis or Thrombus or Embolism, CTCAE","longName":"14634857v1.00","preferredDefinition":"No value exists.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thrombosis or Thrombus or Embolism, CTCAE","conceptCode":"C56747","definition":"No value exists.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECCF-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED0A-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Anesthetic","valueDescription":null,"ValueMeaning":{"publicId":"2746208","version":"1","preferredName":"Anesthetic Agent","longName":"2746208","preferredDefinition":"(an-es-THET-iks) Substances that cause loss of feeling or awareness. Local anesthetics cause loss of feeling in a part of the body. General anesthetics put the person to sleep.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anesthetic Agent","conceptCode":"C245","definition":"A pharmacological agent that acts in a reversible fashion and can be applied either locally or systemically to cause a partial or total loss of sensation and pain or to induce unconsciousness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C175B6C-FBAF-2303-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED0B-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Toothache","valueDescription":null,"ValueMeaning":{"publicId":"2944517","version":"1","preferredName":"Toothache","longName":"2944517","preferredDefinition":"A painful sensation originating from a tooth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Toothache","conceptCode":"C78640","definition":"A painful sensation originating from a tooth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"743C896C-2129-79F1-E040-BB89AD4359CF","latestVersionIndicator":"Yes","beginDate":"2009-09-23","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED0C-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Angina","valueDescription":null,"ValueMeaning":{"publicId":"2574503","version":"1","preferredName":"Angina","longName":"2574503","preferredDefinition":"A heart condition marked by paroxysms of chest pain due to reduced oxygen to the heart.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Angina","conceptCode":"C51221","definition":"Paroxysms of chest pain due to reduced oxygen to the heart.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F014-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-12","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-12","modifiedBy":"CURTIST","dateModified":"2007-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED0D-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Tumor lysis syndrome prophylaxis","valueDescription":null,"ValueMeaning":{"publicId":"14634858","version":"1","preferredName":"Tumor Lysis Syndrome Preventive Intervention","longName":"14634858v1.00","preferredDefinition":"A condition of metabolic abnormalities that result from a spontaneous or therapy-related cytolysis of tumor cells. Tumor lysis syndrome typically occurs in aggressive, rapidly proliferating lymphoproliferative disorders. Burkitt lymphoma and T cell acute lymphoblastic leukemia are commonly associated with this syndrome. Metabolic abnormalities include hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia and may result in renal failure, multiple organ failure, and death._Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Lysis Syndrome","conceptCode":"C3425","definition":"A condition of metabolic abnormalities that result from a spontaneous or therapy-related cytolysis of tumor cells. Tumor lysis syndrome typically occurs in aggressive, rapidly proliferating lymphoproliferative disorders. Burkitt lymphoma and T cell acute lymphoblastic leukemia are commonly associated with this syndrome. Metabolic abnormalities include hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia and may result in renal failure, multiple organ failure, and death.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Preventive Intervention","conceptCode":"C15843","definition":"Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECD0-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED0E-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Anorexia","valueDescription":null,"ValueMeaning":{"publicId":"2562627","version":"1","preferredName":"Anorexia","longName":"2562627","preferredDefinition":"Loss of appetite.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anorexia","conceptCode":"C2875","definition":"Loss of appetite.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C1B0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"CURTIST","dateModified":"2009-09-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED0F-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Anti-bacterial","valueDescription":null,"ValueMeaning":{"publicId":"7848435","version":"1","preferredName":"Antibacterial Agent","longName":"7848435","preferredDefinition":"A family of substances capable of destroying or inhibiting the growth of bacteria.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antibacterial Agent","conceptCode":"C52588","definition":"A family of substances capable of destroying or inhibiting the growth of bacteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D27B79F9-39CC-5F05-E053-4EBD850A3F65","latestVersionIndicator":"Yes","beginDate":"2021-12-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-06","modifiedBy":"ONEDATA","dateModified":"2021-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED10-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Tumor lysis syndrome treatment","valueDescription":null,"ValueMeaning":{"publicId":"14634859","version":"1","preferredName":"Tumor Lysis Syndrome Therapeutic Procedure","longName":"14634859v1.00","preferredDefinition":"A condition of metabolic abnormalities that result from a spontaneous or therapy-related cytolysis of tumor cells. Tumor lysis syndrome typically occurs in aggressive, rapidly proliferating lymphoproliferative disorders. Burkitt lymphoma and T cell acute lymphoblastic leukemia are commonly associated with this syndrome. Metabolic abnormalities include hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia and may result in renal failure, multiple organ failure, and death._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Lysis Syndrome","conceptCode":"C3425","definition":"A condition of metabolic abnormalities that result from a spontaneous or therapy-related cytolysis of tumor cells. Tumor lysis syndrome typically occurs in aggressive, rapidly proliferating lymphoproliferative disorders. Burkitt lymphoma and T cell acute lymphoblastic leukemia are commonly associated with this syndrome. Metabolic abnormalities include hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia and may result in renal failure, multiple organ failure, and death.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECD1-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED11-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Anti-coagulant","valueDescription":null,"ValueMeaning":{"publicId":"3191467","version":"1","preferredName":"Anticoagulant Agent","longName":"3191467","preferredDefinition":"Agents that prevent blood clotting. Naturally occurring agents in the blood are included only when they are used as drugs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anticoagulant Agent","conceptCode":"C263","definition":"Any agent capable of preventing blood clot formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C03939E-97E2-2D26-E040-BB89AD4356ED","latestVersionIndicator":"Yes","beginDate":"2011-02-11","endDate":null,"createdBy":"LUY","dateCreated":"2011-02-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED12-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Tumor pain","valueDescription":null,"ValueMeaning":{"publicId":"2944004","version":"1","preferredName":"Tumor Pain","longName":"2944004","preferredDefinition":"A painful sensation caused by the tumor growth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Pain","conceptCode":"C78656","definition":"A painful sensation caused by the tumor growth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"742DD56B-1150-A7E6-E040-BB89AD43063D","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-09-22","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED13-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Anti-convulsant","valueDescription":null,"ValueMeaning":{"publicId":"3252866","version":"1","preferredName":"Anticonvulsant Agent","longName":"3252866","preferredDefinition":"(an-tee-kon-VUL-sants) Drugs that prevent, reduce, or stop convulsions or seizures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anticonvulsant Agent","conceptCode":"C264","definition":"Medicine to stop, prevent, or control seizures (convulsions).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7F6FE08-9DA9-3DAF-E040-BB89AD43770F","latestVersionIndicator":"Yes","beginDate":"2011-07-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-07-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED14-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Upper respiratory infection/URTI","valueDescription":null,"ValueMeaning":{"publicId":"2944013","version":"1","preferredName":"Upper Respiratory Tract Infection","longName":"2944013","preferredDefinition":"An infectious process affecting the upper respiratory tract (nose, paranasal sinuses, pharynx, larynx, or trachea). Symptoms include congestion, sneezing, coughing, fever, and sore throat.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Upper Respiratory Tract Infection","conceptCode":"C35650","definition":"An infectious process affecting the upper respiratory tract (nose, paranasal sinuses, pharynx, larynx, or trachea). Symptoms include congestion, sneezing, coughing, fever, and sore throat.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"742DD56B-120B-A7E6-E040-BB89AD43063D","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED15-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Anti-fungal","valueDescription":null,"ValueMeaning":{"publicId":"2738678","version":"1","preferredName":"Antifungal Agent","longName":"2738678","preferredDefinition":"Drugs that treat infections caused by fungi.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antifungal Agent","conceptCode":"C514","definition":"Substances that treat systemic or topical infections caused by fungi. Antifungal agents kill or inhibit the growth of fungi, by various mechanisms. These mechanisms include inhibition of fungal mitosis, impairing synthesis or binding to ergosterol, inhibition of RNA or DNA synthesis, and interfering with other fungal metabolic processes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"49E7530B-6457-6451-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-04-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED16-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Vaginitis","valueDescription":null,"ValueMeaning":{"publicId":"2943897","version":"1","preferredName":"Vaginitis","longName":"2943897","preferredDefinition":"An infectious process affecting the vagina. Symptoms include pain and purulent discharge.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vaginitis","conceptCode":"C26911","definition":"A non-infectious or infectious inflammatory process affecting the vagina.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"742AC632-1FF7-2D98-E040-BB89AD432435","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED17-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Anti-inflammatory","valueDescription":null,"ValueMeaning":{"publicId":"14634860","version":"1","preferredName":"Anti-inflammatory","longName":"14634860v1.00","preferredDefinition":"Having to do with reducing inflammation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anti-inflammatory","conceptCode":"C28347","definition":"Having to do with reducing inflammation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECD2-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED18-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Vomiting prophylaxis","valueDescription":null,"ValueMeaning":{"publicId":"14634861","version":"1","preferredName":"Vomiting Preventive Intervention","longName":"14634861v1.00","preferredDefinition":"Forceful ejection of the contents of the stomach through the mouth._Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vomiting","conceptCode":"C3442","definition":"Forceful ejection of the contents of the stomach through the mouth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Preventive Intervention","conceptCode":"C15843","definition":"Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECD3-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED19-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Anti-psychotic","valueDescription":null,"ValueMeaning":{"publicId":"2746207","version":"1","preferredName":"Antipsychotic","longName":"2746207v1.00","preferredDefinition":"Also known as neuroleptics, major tranquilizers, or antischizophrenics, natural or synthetic. Antipsychotic Agents relieve and control the symptoms of schizophrenic illness (hallucinations, delusions, dementia). Most antipsychotic agents interfere with various neurotransmitter functions, often blocking dopamine receptors, and induce diverse behavioral, endocrine, motor-kinetic effects. (NCI04)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antipsychotic Agent","conceptCode":"C29710","definition":"Also known as neuroleptics, major tranquilizers, or antischizophrenics, natural or synthetic. Antipsychotic Agents relieve and control the symptoms of schizophrenic illness (hallucinations, delusions, dementia). Most antipsychotic agents interfere with various neurotransmitter functions, often blocking dopamine receptors, and induce diverse behavioral, endocrine, motor-kinetic effects. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C175B6C-FB74-2303-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"CLOHNES","dateModified":"2023-05-16","changeDescription":null,"administrativeNotes":"5/16/23 updated VM with C29710 per cleanup actitivies cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED1A-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Anti-viral","valueDescription":null,"ValueMeaning":{"publicId":"3235629","version":"1","preferredName":"Antiviral Agent","longName":"3235629","preferredDefinition":"Drugs used to treat infections caused by viruses.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antiviral Agent","conceptCode":"C281","definition":"Any agent that can treat or prevent viral infections by interfering with the viral replication cycle.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A369A0EE-1117-2F9A-E040-BB89AD430C53","latestVersionIndicator":"Yes","beginDate":"2011-05-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED1B-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Vomiting treatment","valueDescription":null,"ValueMeaning":{"publicId":"14634862","version":"1","preferredName":"Vomiting Therapeutic Procedure","longName":"14634862v1.00","preferredDefinition":"Forceful ejection of the contents of the stomach through the mouth._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vomiting","conceptCode":"C3442","definition":"Forceful ejection of the contents of the stomach through the mouth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECD4-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED1C-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Anxiety","valueDescription":null,"ValueMeaning":{"publicId":"2746213","version":"1","preferredName":"Anxiety","longName":"2746213","preferredDefinition":"Apprehension of danger and dread accompanied by restlessness, tension, tachycardia, and dyspnea unattached to a clearly identifiable stimulus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anxiety","conceptCode":"C26696","definition":"Apprehension of danger and dread accompanied by restlessness, tension, tachycardia, and dyspnea unattached to a clearly identifiable stimulus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C175B6C-FCBB-2303-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED1D-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Watering eye","valueDescription":null,"ValueMeaning":{"publicId":"4394270","version":"1","preferredName":"Excessive Tearing","longName":"4394270","preferredDefinition":"Profuse lacrimation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epiphora","conceptCode":"C50552","definition":"Excessive tearing of the eyes due to either tear overproduction or impaired drainage of the tear ducts. Causes of tear overproduction include eye irritation (e.g., eye infection, foreign body in the eye), headache, pain reaction, allergies, sinusitis, and injury to the eye.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB3A0C2-7408-47C7-E040-BB89AD43432D","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED1E-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Other","valueDescription":null,"ValueMeaning":{"publicId":"6431768","version":"1","preferredName":"Other","longName":"6431768v1.00","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"762A692A-EEF7-29A1-E053-F662850A9EA9","latestVersionIndicator":"Yes","beginDate":"2018-09-18","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-09-18","modifiedBy":"GDEEN","dateModified":"2024-01-22","changeDescription":null,"administrativeNotes":"2023.2.1 Alt VM added per ticket request CADSR0001995. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED1F-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Arrhythmia/dysrhythmia","valueDescription":null,"ValueMeaning":{"publicId":"14634863","version":"1","preferredName":"Arrhythmia Or Irregular Heart Beat","longName":"14634863v1.00","preferredDefinition":"Any variation from the normal rate or rhythm (which may include the origin of the impulse and/or its subsequent propagation) in the heart._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A clinical finding in which the rhythm of the heart is noted to be abnormal. (ACC/AHA)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Arrhythmia","conceptCode":"C2881","definition":"Any variation from the normal rate or rhythm (which may include the origin of the impulse and/or its subsequent propagation) in the heart.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Irregular Heart Beat","conceptCode":"C168284","definition":"A clinical finding in which the rhythm of the heart is noted to be abnormal. (ACC/AHA)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECD5-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED20-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Arthralgia/joint pain","valueDescription":null,"ValueMeaning":{"publicId":"2946473","version":"1","preferredName":"Arthralgia","longName":"2946473","preferredDefinition":"Pain in a joint.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Arthralgia","conceptCode":"C50464","definition":"Pain in a joint.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74859E91-BFDC-5A7D-E040-BB89AD431CCA","latestVersionIndicator":"Yes","beginDate":"2009-09-26","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-09-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED21-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Arthritis","valueDescription":null,"ValueMeaning":{"publicId":"3292693","version":"1","preferredName":"Arthritis","longName":"3292693","preferredDefinition":"An inflammatory process affecting a joint. Causes include infection, autoimmune processes, degenerative processes, and trauma. Signs and symptoms may include swelling around the affected joint and pain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Arthritis","conceptCode":"C2883","definition":"An inflammatory process affecting a joint. Causes include infection, autoimmune processes, degenerative processes, and trauma. Signs and symptoms may include swelling around the affected joint and pain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEA65AE0-D99F-3EBD-E040-BB89AD431EBC","latestVersionIndicator":"Yes","beginDate":"2011-10-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED22-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Asthma","valueDescription":null,"ValueMeaning":{"publicId":"2975594","version":"1","preferredName":"Asthma","longName":"2975594","preferredDefinition":"A chronic respiratory disease manifested as difficulty breathing due to the narrowing of bronchial passageways.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Asthma","conceptCode":"C28397","definition":"A chronic respiratory disease manifested as difficulty breathing due to the narrowing of bronchial passageways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C08420A-B206-2A47-E040-BB89AD433D97","latestVersionIndicator":"Yes","beginDate":"2009-12-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED23-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Atrial fibrillation","valueDescription":null,"ValueMeaning":{"publicId":"2760267","version":"1","preferredName":"Atrial Fibrillation","longName":"2760267","preferredDefinition":"A supraventricular arrhythmia characterized by uncoordinated atrial myocardium activation due to multiple reentry circuits with consequent deterioration of atrial mechanical function. Instead of intermittently contracting, the atria quiver continuously in a chaotic pattern, causing a totally irregular, often tachycardia ventricular rate. On the ECG it is described by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape, and timing, associated with an irregular, frequently rapid ventricular response when atrioventricular conduction is intact.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atrial Fibrillation","conceptCode":"C50466","definition":"A disorder characterized by an electrocardiographic finding of a supraventricular arrhythmia characterized by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape and timing and are accompanied by an irregular ventricular response. (CDISC)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4FF5CBC6-3C42-1060-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-06-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED24-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Autoimmune disorder","valueDescription":null,"ValueMeaning":{"publicId":"2585785","version":"1","preferredName":"Autoimmune Disease","longName":"2585785","preferredDefinition":"A disorder resulting from loss of function or tissue destruction of an organ or multiple organs, arising from humoral or cellular immune responses of the individual to his own tissue constituents. It may be systemic (e.g., systemic lupus erythematosus), or organ specific, (e.g., thyroiditis). \r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Autoimmune Disease","conceptCode":"C2889","definition":"A disorder resulting from loss of function or tissue destruction of an organ or multiple organs, arising from humoral or cellular immune responses of the individual to his own tissue constituents. It may be systemic (e.g., systemic lupus erythematosus), or organ specific, (e.g., thyroiditis).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"26B7A966-8345-0BC2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-10","modifiedBy":"TAYLORT","dateModified":"2020-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED25-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Back pain","valueDescription":null,"ValueMeaning":{"publicId":"2944080","version":"1","preferredName":"Back Pain","longName":"2944080","preferredDefinition":"Painful sensation in the back region.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Back Pain","conceptCode":"C41830","definition":"Painful sensation in the back region.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"742DD56B-1490-A7E6-E040-BB89AD43063D","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED26-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Bone pain","valueDescription":null,"ValueMeaning":{"publicId":"2944116","version":"1","preferredName":"Bone Pain","longName":"2944116","preferredDefinition":"Painful sensation in the bones.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bone Pain","conceptCode":"C38644","definition":"Painful sensation in the bones.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74301D2A-4A92-F34C-E040-BB89AD430317","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED27-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Bronchospasm","valueDescription":null,"ValueMeaning":{"publicId":"2944275","version":"1","preferredName":"Bronchospasm","longName":"2944275","preferredDefinition":"Sudden contraction of the smooth muscles of the bronchial wall.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bronchospasm","conceptCode":"C34439","definition":"Sudden contraction of the smooth muscles of the bronchial wall.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74301D2A-4B99-F34C-E040-BB89AD430317","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED28-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Cardiac prophylaxis","valueDescription":null,"ValueMeaning":{"publicId":"14634864","version":"1","preferredName":"Cardiac Preventive Intervention","longName":"14634864v1.00","preferredDefinition":"Having to do with the heart._Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cardiac","conceptCode":"C13306","definition":"Having to do with the heart.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Preventive Intervention","conceptCode":"C15843","definition":"Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECD6-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED29-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Cataract","valueDescription":null,"ValueMeaning":{"publicId":"2797325","version":"1","preferredName":"Cataract","longName":"2797325","preferredDefinition":"Partial or complete opacity of the crystalline lens of one or both eyes that decreases visual acuity and eventually results in blindness.  Some cataracts appear in infancy or in childhood, but most develop in older individuals. (Diagnostic Surgical Pathology, 3rd ed.) --2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cataract","conceptCode":"C26713","definition":"Partial or complete opacity of the crystalline lens of one or both eyes that decreases visual acuity and eventually results in blindness. Some cataracts appear in infancy or in childhood, but most develop in older individuals. (Sternberg Diagnostic Surgical Pathology, 3rd ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5AD63DAD-D834-12B9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-11-03","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED2A-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Chest pain - non-cardiac","valueDescription":null,"ValueMeaning":{"publicId":"2945867","version":"1","preferredName":"Non-Cardiac Chest Pain","longName":"2945867","preferredDefinition":"Pain in the chest unrelated to a heart disorder.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Cardiac Chest Pain","conceptCode":"C78504","definition":"Pain in the chest unrelated to a heart disorder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74597246-17D8-6D19-E040-BB89AD431E08","latestVersionIndicator":"Yes","beginDate":"2009-09-24","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED2B-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Chest wall pain","valueDescription":null,"ValueMeaning":{"publicId":"2944289","version":"1","preferredName":"Chest Wall Pain","longName":"2944289","preferredDefinition":"Painful sensation in the chest wall region.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chest Wall Pain","conceptCode":"C78238","definition":"Painful sensation in the chest wall region.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74301D2A-4DF8-F34C-E040-BB89AD430317","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED2C-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Chills","valueDescription":null,"ValueMeaning":{"publicId":"2739031","version":"1","preferredName":"Chills","longName":"2739031","preferredDefinition":"Chills; a sensation of cold that often marks the start of an infection and the development of a fever.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chills","conceptCode":"C35143","definition":"Shivering or moderate tremors of the body often accompanied by a cold sensation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A10AF04-DDB2-45CE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED2D-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Chronic obstructive pulmonary disease/COPD","valueDescription":null,"ValueMeaning":{"publicId":"4395784","version":"1","preferredName":"Chronic Obstructive Pulmonary Disease","longName":"4395784","preferredDefinition":"A chronic and progressive lung disorder characterized by the loss of elasticity of the bronchial tree and the air sacs, destruction of the air sacs wall, thickening of the bronchial wall, and mucous accumulation in the bronchial tree. The pathologic changes result in the disruption of the air flow in the bronchial airways. Signs and symptoms include shortness of breath, wheezing, productive cough, and chest tightness. The two main types of chronic obstructive pulmonary disease are chronic obstructive bronchitis and emphysema.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Obstructive Pulmonary Disease","conceptCode":"C3199","definition":"A chronic and progressive lung disorder characterized by the loss of elasticity of the bronchial tree and the air sacs, destruction of the air sacs wall, thickening of the bronchial wall, and mucous accumulation in the bronchial tree. The pathologic changes result in the disruption of the air flow in the bronchial airways. Signs and symptoms include shortness of breath, wheezing, productive cough, and chest tightness. The two main types of chronic obstructive pulmonary disease are chronic obstructive bronchitis and emphysema.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-DB13-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED2E-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Confusion","valueDescription":null,"ValueMeaning":{"publicId":"4614753","version":"1","preferredName":"Confusion","longName":"4614753","preferredDefinition":"Impaired orientation to person, place or time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Confusion","conceptCode":"C37928","definition":"A mental state characterized by a lack of clear and orderly thought and behavior.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"08EE1F25-CD68-F7EA-E050-BB89AD432750","latestVersionIndicator":"Yes","beginDate":"2014-11-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-11-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED2F-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Constipation prophylaxis","valueDescription":null,"ValueMeaning":{"publicId":"14634865","version":"1","preferredName":"Constipation Preventive Intervention","longName":"14634865v1.00","preferredDefinition":"Irregular and infrequent or difficult evacuation of the bowels._Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Constipation","conceptCode":"C37930","definition":"Irregular and infrequent or difficult evacuation of the bowels.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Preventive Intervention","conceptCode":"C15843","definition":"Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECD7-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED30-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Constipation treatment","valueDescription":null,"ValueMeaning":{"publicId":"14634866","version":"1","preferredName":"Constipation Therapeutic Procedure","longName":"14634866v1.00","preferredDefinition":"Irregular and infrequent or difficult evacuation of the bowels._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Constipation","conceptCode":"C37930","definition":"Irregular and infrequent or difficult evacuation of the bowels.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECD8-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED31-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Cough","valueDescription":null,"ValueMeaning":{"publicId":"2946357","version":"1","preferredName":"Cough","longName":"2946357","preferredDefinition":"A sudden, often repetitive, spasmodic contraction of the thoracic cavity, resulting in violent release of air from the lungs, and usually accompanied by a distinctive sound.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cough","conceptCode":"C37935","definition":"A sudden, often repetitive, spasmodic contraction of the thoracic cavity, resulting in violent release of air from the lungs, and usually accompanied by a distinctive sound.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746D32D6-F965-1467-E040-BB89AD436E21","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED32-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Cytokine release syndrome","valueDescription":null,"ValueMeaning":{"publicId":"2946552","version":"1","preferredName":"Cytokine Release Syndrome","longName":"2946552","preferredDefinition":"A syndrome that occurs after therapeutic infusion of antibodies into the blood and is characterized by nausea, headache, tachycardia, hypotension, rash, and shortness of breath. It is caused by the release of cytokines from the cells that are targeted by the antibodies. Most patients experience a mild to moderate reaction; however, the reaction may be severe and life-threatening.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytokine Release Syndrome","conceptCode":"C78251","definition":"A syndrome that occurs after therapeutic infusion of antibodies into the blood and is characterized by nausea, headache, tachycardia, hypotension, rash, and shortness of breath. It is caused by the release of cytokines from the cells that are targeted by the antibodies. Most patients experience a mild to moderate reaction; however, the reaction may be severe and life-threatening.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74A40B1A-E861-30F2-E040-BB89AD4307C8","latestVersionIndicator":"Yes","beginDate":"2009-09-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-09-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED33-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Dehydration prophylaxis","valueDescription":null,"ValueMeaning":{"publicId":"14634867","version":"1","preferredName":"Dehydration Preventive Intervention","longName":"14634867v1.00","preferredDefinition":"A condition resulting from the excessive loss of water from the body. It is usually caused by severe diarrhea, vomiting or diaphoresis._Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dehydration","conceptCode":"C26740","definition":"A condition resulting from the excessive loss of water from the body. It is usually caused by severe diarrhea, vomiting or diaphoresis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Preventive Intervention","conceptCode":"C15843","definition":"Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECD9-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED34-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Dehydration treatment","valueDescription":null,"ValueMeaning":{"publicId":"14634868","version":"1","preferredName":"Dehydration Therapeutic Procedure","longName":"14634868v1.00","preferredDefinition":"A condition resulting from the excessive loss of water from the body. It is usually caused by severe diarrhea, vomiting or diaphoresis._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dehydration","conceptCode":"C26740","definition":"A condition resulting from the excessive loss of water from the body. It is usually caused by severe diarrhea, vomiting or diaphoresis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECDA-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED35-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Depression","valueDescription":null,"ValueMeaning":{"publicId":"2746223","version":"1","preferredName":"Depression","longName":"2746223","preferredDefinition":"Depression; a mental state of depressed mood characterised by feelings of sadness, despair and discouragement. (On-line Medical Dictionary)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Depression","conceptCode":"C2982","definition":"A melancholy feeling of sadness and despair.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C16B073-3A2F-3FCC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED36-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Diabetes","valueDescription":null,"ValueMeaning":{"publicId":"3292684","version":"1","preferredName":"Diabetes Mellitus","longName":"3292684","preferredDefinition":"A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diabetes Mellitus","conceptCode":"C2985","definition":"A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEA65AE0-D82E-3EBD-E040-BB89AD431EBC","latestVersionIndicator":"Yes","beginDate":"2011-10-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-06","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED37-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Diarrhea prophylaxis","valueDescription":null,"ValueMeaning":{"publicId":"14634869","version":"1","preferredName":"Diarrhea Preventive Intervention","longName":"14634869v1.00","preferredDefinition":"Watery bowel movements._Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diarrhea","conceptCode":"C2987","definition":"Watery bowel movements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Preventive Intervention","conceptCode":"C15843","definition":"Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECDB-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED38-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Diarrhea treatment","valueDescription":null,"ValueMeaning":{"publicId":"14634870","version":"1","preferredName":"Diarrhea Therapeutic Procedure","longName":"14634870v1.00","preferredDefinition":"Watery bowel movements._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diarrhea","conceptCode":"C2987","definition":"Watery bowel movements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECDC-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED39-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Diuretic","valueDescription":null,"ValueMeaning":{"publicId":"6422927","version":"1","preferredName":"Diuretic","longName":"6422927","preferredDefinition":"A class of agents that increases the production of urine by the kidney. Via various mechanism of actions, diuretics retain water in urine, thus provides a means of forced diuresis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diuretic","conceptCode":"C448","definition":"A class of agents that increases the production of urine by the kidney. Via various mechanism of actions, diuretics retain water in urine, thus provides a means of forced diuresis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74AAE53F-EF02-6E81-E053-F662850A3492","latestVersionIndicator":"Yes","beginDate":"2018-08-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-08-30","modifiedBy":"ONEDATA","dateModified":"2018-08-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED3A-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Dizziness","valueDescription":null,"ValueMeaning":{"publicId":"10134618","version":"1","preferredName":"Lightheadedness or Dizziness","longName":"10134618v1.00","preferredDefinition":"A sensation of lightheadedness, unsteadiness, turning, spinning or rocking.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dizziness","conceptCode":"C37943","definition":"A sensation of lightheadedness, unsteadiness, turning, spinning or rocking.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDE5A4E5-3A86-5E37-E053-731AD00A299D","latestVersionIndicator":"Yes","beginDate":"2022-05-03","endDate":null,"createdBy":"RAGUNATHANU","dateCreated":"2022-05-03","modifiedBy":"MMADDINENI","dateModified":"2022-06-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED3B-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Dry eye","valueDescription":null,"ValueMeaning":{"publicId":"2944487","version":"1","preferredName":"Dry Eye Syndrome","longName":"2944487","preferredDefinition":"A syndrome characterized by dryness of the cornea and conjunctiva. It is usually caused by a deficiency in tear production. Symptoms include a feeling of burning eyes and a possible foreign body presence in the eye.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dry Eye Syndrome","conceptCode":"C34553","definition":"A syndrome characterized by dryness of the cornea and conjunctiva. It is usually caused by a deficiency in tear production. Symptoms include a feeling of burning eyes and a possible foreign body presence in the eye.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74331C4B-D72C-D41C-E040-BB89AD435AA5","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED3C-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Dry mouth","valueDescription":null,"ValueMeaning":{"publicId":"2944511","version":"1","preferredName":"Xerostomia","longName":"2944511","preferredDefinition":"An oral condition in which salivary flow is reduced. --2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Xerostomia","conceptCode":"C26917","definition":"Dryness of the oral mucosa secondary to a decrease in saliva production, or a change in saliva composition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"743C896C-1FCC-79F1-E040-BB89AD4359CF","latestVersionIndicator":"Yes","beginDate":"2009-09-23","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED3D-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Dry skin","valueDescription":null,"ValueMeaning":{"publicId":"2919162","version":"1","preferredName":"Dry Skin","longName":"2919162","preferredDefinition":"The pores are generally fine with a papery thin texture that feels dry to the touch. Usually flaky and dull looking.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dry Skin","conceptCode":"C74592","definition":"The pores are generally fine with a papery thin texture that feels dry to the touch. Usually flaky and dull looking.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6EBE8C49-2918-36F8-E040-BB89AD434A81","latestVersionIndicator":"Yes","beginDate":"2009-07-15","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-07-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED3E-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Dyspepsia/heartburn/acid reflux/GERD","valueDescription":null,"ValueMeaning":{"publicId":"14634871","version":"1","preferredName":"Dyspepsia Heartburn Have Acid Reflux Or Gastroesophageal Reflux Disease","longName":"14634871v1.00","preferredDefinition":"An uncomfortable, often painful feeling in the stomach, resulting from impaired digestion. Symptoms include burning stomach pain, bloating, heartburn, nausea, and vomiting. Causes include gastritis, gastric ulcer, gastroesophageal reflux disease, pancreatic disease, and gallbladder disease._Abdominal discomfort with retrosternal pain usually associated with gastroesophageal reflux._A question about whether an individual has or had acid reflux._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A chronic disorder characterized by reflux of the gastric and/or duodenal contents into the distal esophagus. It is usually caused by incompetence of the lower esophageal sphincter. Symptoms include heartburn and acid indigestion. It may cause injury to the esophageal mucosa.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dyspepsia","conceptCode":"C26756","definition":"An uncomfortable, often painful feeling in the stomach, resulting from impaired digestion. Symptoms include burning stomach pain, bloating, heartburn, nausea, and vomiting. Causes include gastritis, gastric ulcer, gastroesophageal reflux disease, pancreatic disease, and gallbladder disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Heartburn","conceptCode":"C34670","definition":"Abdominal discomfort with retrosternal pain usually associated with gastroesophageal reflux.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Have Acid Reflux","conceptCode":"C116988","definition":"A question about whether an individual has or had acid reflux.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Gastroesophageal Reflux Disease","conceptCode":"C26781","definition":"A chronic disorder characterized by reflux of the gastric and/or duodenal contents into the distal esophagus. It is usually caused by incompetence of the lower esophageal sphincter. Symptoms include heartburn and acid indigestion. It may cause injury to the esophageal mucosa.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECDD-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED3F-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Dyspnea","valueDescription":null,"ValueMeaning":{"publicId":"4395746","version":"1","preferredName":"Dyspnea","longName":"4395746","preferredDefinition":"Difficult, painful breathing or shortness of breath.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dyspnea","conceptCode":"C2998","definition":"An uncomfortable sensation of difficulty breathing. It may present as an acute or chronic sign of an underlying respiratory or heart disorder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D5EA-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED40-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Ear pain/earache","valueDescription":null,"ValueMeaning":{"publicId":"2944375","version":"1","preferredName":"Earache","longName":"2944375","preferredDefinition":"Earache; a pain localized in the middle or inner ear.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ear Pain","conceptCode":"C37944","definition":"Painful sensation in the ear region.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7431FEA7-FB01-A5C9-E040-BB89AD4324B4","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED41-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Edema","valueDescription":null,"ValueMeaning":{"publicId":"3637928","version":"1","preferredName":"Edema","longName":"3637928","preferredDefinition":"Accumulation of an excessive amount of watery fluid in cells or intercellular tissues.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Edema","conceptCode":"C3002","definition":"Accumulation of an excessive amount of fluid in cells or intercellular tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D0209A7E-B986-D19B-E040-BB89AD432DDA","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED42-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Erectile dysfunction","valueDescription":null,"ValueMeaning":{"publicId":"5092377","version":"1","preferredName":"Impotence","longName":"5092377","preferredDefinition":"Persistent or recurrent inability to achieve or to maintain an erection during sexual activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Erectile Dysfunction","conceptCode":"C3133","definition":"A disorder characterized by the persistent or recurrent inability to achieve or to maintain an erection during sexual activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"276B7749-4983-6628-E050-BB89AD432248","latestVersionIndicator":"Yes","beginDate":"2015-12-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-12-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED43-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Fatigue","valueDescription":null,"ValueMeaning":{"publicId":"4395775","version":"1","preferredName":"Fatigue","longName":"4395775","preferredDefinition":"Overall tiredness and lack of energy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fatigue","conceptCode":"C3036","definition":"Overall tiredness and lack of energy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D9D8-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED44-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Febrile neutropenia prophylaxis","valueDescription":null,"ValueMeaning":{"publicId":"14634872","version":"1","preferredName":"Febrile Neutropenia Preventive Intervention","longName":"14634872v1.00","preferredDefinition":"Neutropenia associated with fever, the latter indicating the presence of an infection._Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Febrile Neutropenia","conceptCode":"C35665","definition":"Neutropenia associated with fever, the latter indicating the presence of an infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Preventive Intervention","conceptCode":"C15843","definition":"Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECDE-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED45-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Febrile neutropenia treatment","valueDescription":null,"ValueMeaning":{"publicId":"14634873","version":"1","preferredName":"Febrile Neutropenia Therapeutic Procedure","longName":"14634873v1.00","preferredDefinition":"Neutropenia associated with fever, the latter indicating the presence of an infection._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Febrile Neutropenia","conceptCode":"C35665","definition":"Neutropenia associated with fever, the latter indicating the presence of an infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECDF-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED46-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Fever","valueDescription":null,"ValueMeaning":{"publicId":"10134616","version":"1","preferredName":"Fever >100.4 F","longName":"10134616v1.00","preferredDefinition":"Elevation of body temperature above normal due to inflammatory or immune responses.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fever","conceptCode":"C3038","definition":"Elevation of body temperature above normal due to inflammatory or immune responses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDE5A4E5-3A83-5E37-E053-731AD00A299D","latestVersionIndicator":"Yes","beginDate":"2022-05-03","endDate":null,"createdBy":"RAGUNATHANU","dateCreated":"2022-05-03","modifiedBy":"RAGUNATHANU","dateModified":"2022-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED47-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Flu-like symptoms","valueDescription":null,"ValueMeaning":{"publicId":"2944831","version":"1","preferredName":"Flu-Like Symptoms","longName":"2944831","preferredDefinition":"A group of symptoms similar to those observed in patients with the flu. It includes fever, chills, body aches, malaise, loss of appetite, and dry cough. Flu-like symptoms are observed in patients infected with various viruses, including hepatitis virus and HIV (initial phase), and with malignancies.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Flu-Like Symptoms","conceptCode":"C78302","definition":"Complaints describing a pattern similar to influenza, which may include one or more of the following symptoms: fever, chills, muscle or body aches, cough, sore throat, rhinitis, or fatigue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74450F48-343C-F0DB-E040-BB89AD437C48","latestVersionIndicator":"Yes","beginDate":"2009-09-23","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED48-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Gastritis","valueDescription":null,"ValueMeaning":{"publicId":"2746385","version":"1","preferredName":"Gastritis","longName":"2746385","preferredDefinition":"Inflammation of the lining of the stomach.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastritis","conceptCode":"C26780","definition":"Inflammation of the stomach.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C20DB99-72BF-0BA9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED49-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"General health/wellbeing","valueDescription":null,"ValueMeaning":{"publicId":"14634874","version":"1","preferredName":"Health Status Or Overall Well-Being","longName":"14634874v1.00","preferredDefinition":"The state of a subject's mental or physical condition._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A question about an individual's overall well-being.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Health Status","conceptCode":"C16669","definition":"The state of a subject's mental or physical condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Overall Well-Being","conceptCode":"C107400","definition":"A question about an individual's overall well-being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECE0-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED4A-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"GI/abdominal pain","valueDescription":null,"ValueMeaning":{"publicId":"14634875","version":"1","preferredName":"Gastrointestinal Pain Or Abdominal Pain","longName":"14634875v1.00","preferredDefinition":"Painful sensation in the gastrointestinal region._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Painful sensation in the abdominal region.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastrointestinal Pain","conceptCode":"C78320","definition":"Painful sensation in the gastrointestinal region.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Abdominal Pain","conceptCode":"C26682","definition":"Painful sensation in the abdominal region.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECE1-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED4B-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Glaucoma","valueDescription":null,"ValueMeaning":{"publicId":"4395747","version":"1","preferredName":"Glaucoma","longName":"4395747","preferredDefinition":"Increased pressure in the eyeball due to obstruction of the outflow of aqueous humor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glaucoma","conceptCode":"C26782","definition":"Increased pressure in the eyeball due to obstruction of the outflow of aqueous humor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D60D-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED4C-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Head pain/headache","valueDescription":null,"ValueMeaning":{"publicId":"14634876","version":"1","preferredName":"Hurt or Pain Other Than Headache Or Headache","longName":"14634876v1.00","preferredDefinition":"A question about whether an individual has or had pain other than headache._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Pain in various parts of the head, not confined to the area of distribution of any nerve.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hurt or Pain Other Than Headache","conceptCode":"C156111","definition":"A question about whether an individual has or had pain other than headache.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Headache","conceptCode":"C34661","definition":"Pain in various parts of the head, not confined to the area of distribution of any nerve.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECE2-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED4D-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Heart failure","valueDescription":null,"ValueMeaning":{"publicId":"4827929","version":"1","preferredName":"Heart Failure","longName":"4827929","preferredDefinition":"Inability of the heart to pump blood at an adequate rate to meet tissue metabolic requirements. Clinical symptoms of heart failure include: unusual dyspnea on light exertion, recurrent dyspnea occurring in the supine position, fluid retention or rales, jugular venous distension, pulmonary edema on physical exam, or pulmonary edema on chest x-ray presumed to be cardiac dysfunction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Heart Failure","conceptCode":"C50577","definition":"Inability of the heart to pump blood at an adequate rate to meet tissue metabolic requirements. Clinical symptoms of heart failure include: unusual dyspnea on light exertion, recurrent dyspnea occurring in the supine position, fluid retention or rales, jugular venous distension, pulmonary edema on physical exam, or pulmonary edema on chest x-ray presumed to be cardiac dysfunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"166470EB-F439-9810-E050-BB89AD4311C9","latestVersionIndicator":"Yes","beginDate":"2015-05-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED4E-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Hemorrhage","valueDescription":null,"ValueMeaning":{"publicId":"4395748","version":"1","preferredName":"Hemorrhage","longName":"4395748","preferredDefinition":"Bleeding or escape of blood from a vessel.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemorrhage","conceptCode":"C26791","definition":"The flow of blood from a ruptured blood vessel.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D630-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED4F-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Hemorrhoids","valueDescription":null,"ValueMeaning":{"publicId":"2945730","version":"1","preferredName":"Hemorrhoid","longName":"2945730","preferredDefinition":"Dilated veins in the rectum and anal area.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemorrhoid","conceptCode":"C26792","definition":"Dilated veins in the anal canal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"745580E8-4BD0-8FA9-E040-BB89AD433702","latestVersionIndicator":"Yes","beginDate":"2009-09-24","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED50-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Hormone replacement","valueDescription":null,"ValueMeaning":{"publicId":"2737180","version":"1","preferredName":"Hormone Replacement Therapy","longName":"2737180","preferredDefinition":"RAEB: Treatment with estrogens or estrogen/progesterone after menopause or ovariectomy to prevent pathological effects of decreased estrogen production.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hormone Replacement Therapy","conceptCode":"C15599","definition":"Treatment with estrogens or estrogen/progesterone after menopause or ovariectomy to prevent pathological effects of decreased estrogen production.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"496C593B-2E81-0AFE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"MAESKEB","dateCreated":"2008-03-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED51-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Hot flashes","valueDescription":null,"ValueMeaning":{"publicId":"2751385","version":"1","preferredName":"Hot Flashes","longName":"2751385","preferredDefinition":"A sudden, temporary onset of body warmth, flushing, and sweating (often associated with menopause).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hot Flashes","conceptCode":"C3109","definition":"A temporary feeling of intense body warmth, flushing, sometimes accompanied by sweating. A common, symptom of menopause; other conditions that can produce hot flushes include antidepressants and drugs blocking the effect of estrogens, carcinoid tumors and a sensitivity to sulfites or other food additives.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-085A-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED52-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Hypercholesterolemia/high cholesterol","valueDescription":null,"ValueMeaning":{"publicId":"2751387","version":"1","preferredName":"Hypercholesterolemia","longName":"2751387","preferredDefinition":"Hypercholesterolemia; the presence of an abnormal amount of cholesterol in the cells and plasma of the blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypercholesterolemia","conceptCode":"C37967","definition":"A laboratory test result indicating an increased amount of cholesterol in the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-08A4-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED53-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Hyperlipidemia/high lipids","valueDescription":null,"ValueMeaning":{"publicId":"2751390","version":"1","preferredName":"Hyperlipidemia","longName":"2751390","preferredDefinition":"An excess of lipids in the blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyperlipidemia","conceptCode":"C34707","definition":"Elevated levels of lipids in the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-0915-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED54-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Hyperpigmentation","valueDescription":null,"ValueMeaning":{"publicId":"2944640","version":"1","preferredName":"Skin Hyperpigmentation","longName":"2944640","preferredDefinition":"Darkening of the skin due to excessive melanin deposition. Causes include skin injuries, pregnancy, eczema, and Addison disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin Hyperpigmentation","conceptCode":"C79731","definition":"Darkening of the skin due to excessive melanin deposition. Causes include skin injuries, pregnancy, eczema, and Addison disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7440E944-6921-CDD0-E040-BB89AD431DF0","latestVersionIndicator":"Yes","beginDate":"2009-09-23","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED55-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Hypertension","valueDescription":null,"ValueMeaning":{"publicId":"2562555","version":"1","preferredName":"Hypertension","longName":"2562555","preferredDefinition":"Abnormally high blood pressure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypertension","conceptCode":"C3117","definition":"Blood pressure that is abnormally high.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C168-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-04","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-10-04","modifiedBy":"ZHANGW","dateModified":"2008-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED56-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Hyperthyroidism","valueDescription":null,"ValueMeaning":{"publicId":"2946188","version":"1","preferredName":"Hyperthyroidism","longName":"2946188","preferredDefinition":"Overactivity of the thyroid gland resulting in overproduction of thyroid hormone and increased metabolic rate. Causes include diffuse hyperplasia of the thyroid gland (Graves' disease), single nodule in the thyroid gland, and thyroiditis. The symptoms are related to the increased metabolic rate and include weight loss, fatigue, heat intolerance, excessive sweating, diarrhea, tachycardia, insomnia, muscle weakness, and tremor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyperthyroidism","conceptCode":"C3123","definition":"Overactivity of the thyroid gland resulting in overproduction of thyroid hormone and increased metabolic rate. Causes include diffuse hyperplasia of the thyroid gland (Graves' disease), single nodule in the thyroid gland, and thyroiditis. The symptoms are related to the increased metabolic rate and include weight loss, fatigue, heat intolerance, excessive sweating, diarrhea, tachycardia, insomnia, muscle weakness, and tremor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746BFDBA-4B32-B144-E040-BB89AD4341DF","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED57-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Hyperuricemia/high uric acid/gout","valueDescription":null,"ValueMeaning":{"publicId":"14634877","version":"1","preferredName":"Hyperuricemia Increased Uric Acid Level Or Gout","longName":"14634877v1.00","preferredDefinition":"Elevated blood concentrations of uric acid._A laboratory test result indicating abnormally high concentration of uric acid in the blood._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A condition characterized by painful swelling of the joints, which is caused by deposition of urate crystals.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyperuricemia","conceptCode":"C3961","definition":"Elevated blood concentrations of uric acid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Increased Uric Acid Level","conceptCode":"C35105","definition":"A laboratory test result indicating abnormally high concentration of uric acid in the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Gout","conceptCode":"C34650","definition":"A condition characterized by painful swelling of the joints, which is caused by deposition of urate crystals.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECE3-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED58-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Hypokalemia/low potassium","valueDescription":null,"ValueMeaning":{"publicId":"2751400","version":"1","preferredName":"Hypokalemia","longName":"2751400","preferredDefinition":"Hypokalemia; lower than normal levels of potassium in the circulating blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypokalemia","conceptCode":"C37974","definition":"Lower than normal levels of potassium in the circulating blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-0A5D-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED59-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Hypomagnesemia/low magnesium","valueDescription":null,"ValueMeaning":{"publicId":"2751401","version":"1","preferredName":"Hypomagnesemia","longName":"2751401","preferredDefinition":"Hypermagnesemia; lower than normal levels of magnesium in the circulating blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypomagnesemia","conceptCode":"C37975","definition":"Lower than normal levels of magnesium in the circulating blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-0A82-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED5A-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Hypopigmentation","valueDescription":null,"ValueMeaning":{"publicId":"2944642","version":"1","preferredName":"Skin Hypopigmentation","longName":"2944642","preferredDefinition":"Loss of skin pigment. Vitiligo, albinism, and leukoderma are among the disorders that are associated with skin hypopigmentation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin Hypopigmentation","conceptCode":"C78610","definition":"Abnormal lightening of skin due to decreased melanin production or deposition. Vitiligo, albinism, and leukoderma are among the disorders that are associated with skin hypopigmentation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7440E944-6947-CDD0-E040-BB89AD431DF0","latestVersionIndicator":"Yes","beginDate":"2009-09-23","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED5B-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Hypotension","valueDescription":null,"ValueMeaning":{"publicId":"4395785","version":"1","preferredName":"Hypotension","longName":"4395785","preferredDefinition":"Blood pressure that is abnormally low.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypotension","conceptCode":"C3128","definition":"Blood pressure that is abnormally low.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-DB36-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED5C-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Hypothyroidism","valueDescription":null,"ValueMeaning":{"publicId":"2562672","version":"1","preferredName":"Hypothyroidism","longName":"2562672","preferredDefinition":"A condition in which the production of thyroid hormone by the thyroid gland is diminished. Signs and symptoms of hypothyroidism include low metabolic rate, tendency to weight gain, somnolence and sometimes myxedema. In the United States, the most common cause of hypothyroidism is Hashimoto's thyroiditis, an autoimmune disorder. SYN athyrea. --2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypothyroidism","conceptCode":"C26800","definition":"Abnormally low levels of thyroid hormone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C1DD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"COOPERM","dateModified":"2008-11-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED5D-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Incontinence","valueDescription":null,"ValueMeaning":{"publicId":"4394559","version":"1","preferredName":"Incontinence","longName":"4394559","preferredDefinition":"Inability to control the flow of urine from the bladder (urinary incontinence) or the escape of stool from the rectum (fecal incontinence).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Incontinence","conceptCode":"C3429","definition":"Involuntary passage of stool or urine from the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB4F6BC-3A3E-C771-E040-BB89AD434694","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED5E-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Infection prophylaxis","valueDescription":null,"ValueMeaning":{"publicId":"14634878","version":"1","preferredName":"Infection Preventive Intervention","longName":"14634878v1.00","preferredDefinition":"The invasion of an organism's body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce._Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infection","conceptCode":"C128320","definition":"The invasion of an organism's body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Preventive Intervention","conceptCode":"C15843","definition":"Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECE4-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED5F-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Infection treatment","valueDescription":null,"ValueMeaning":{"publicId":"14634879","version":"1","preferredName":"Infection Therapeutic Procedure","longName":"14634879v1.00","preferredDefinition":"The invasion of an organism's body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infection","conceptCode":"C128320","definition":"The invasion of an organism's body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECE5-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED60-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Injection site reaction","valueDescription":null,"ValueMeaning":{"publicId":"2751404","version":"1","preferredName":"Injection Site Reaction","longName":"2751404","preferredDefinition":"An intense reaction (usually immunologic) developing at the site of injection","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Injection Site Reaction","conceptCode":"C3508","definition":"An intense reaction (usually immunologic) developing at the site of injection","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-0B23-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED61-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Insomnia","valueDescription":null,"ValueMeaning":{"publicId":"2751405","version":"1","preferredName":"Insomnia","longName":"2751405","preferredDefinition":"Difficulty in going to sleep or getting enough sleep.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Insomnia","conceptCode":"C28286","definition":"A sleep disorder characterized by difficulty in falling asleep and/or remaining asleep.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-0B48-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED62-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Keratitis","valueDescription":null,"ValueMeaning":{"publicId":"2944326","version":"1","preferredName":"Keratitis","longName":"2944326","preferredDefinition":"Inflammation of the cornea.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Keratitis","conceptCode":"C26805","definition":"Inflammation of the cornea.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74301D2A-50DA-F34C-E040-BB89AD430317","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED63-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Motor neuropathy","valueDescription":null,"ValueMeaning":{"publicId":"2946009","version":"1","preferredName":"Peripheral Motor Neuropathy","longName":"2946009","preferredDefinition":"Inflammation or degeneration of the peripheral motor nerves. - 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Peripheral Motor Neuropathy","conceptCode":"C3500","definition":"Inflammation or degeneration of the peripheral motor nerves.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746944AF-42C6-DCDB-E040-BB89AD437B02","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED64-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Mucositis prophylaxis","valueDescription":null,"ValueMeaning":{"publicId":"14634880","version":"1","preferredName":"Mucositis Preventive Intervention","longName":"14634880v1.00","preferredDefinition":"Inflammation of the mucous membranes._Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mucositis","conceptCode":"C115965","definition":"Inflammation of the mucous membranes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Preventive Intervention","conceptCode":"C15843","definition":"Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECE6-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED65-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Mucositis treatment","valueDescription":null,"ValueMeaning":{"publicId":"14634881","version":"1","preferredName":"Mucositis Therapeutic Procedure","longName":"14634881v1.00","preferredDefinition":"Inflammation of the mucous membranes._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mucositis","conceptCode":"C115965","definition":"Inflammation of the mucous membranes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECE7-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED66-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Muscle weakness","valueDescription":null,"ValueMeaning":{"publicId":"4394508","version":"1","preferredName":"Muscle Weakness","longName":"4394508","preferredDefinition":"A reduction in the strength of one or more muscles.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Muscle Weakness","conceptCode":"C50658","definition":"A reduction in the strength of one or more muscles.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB4F6BC-35D4-C771-E040-BB89AD434694","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED67-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Myalgia/muscle pain","valueDescription":null,"ValueMeaning":{"publicId":"2946019","version":"1","preferredName":"Myalgia","longName":"2946019","preferredDefinition":"Painful sensation originating from a muscle or group of muscles.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myalgia","conceptCode":"C27009","definition":"Painful sensation originating from a muscle or group of muscles.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746944AF-43A5-DCDB-E040-BB89AD437B02","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED68-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Nasal congestion","valueDescription":null,"ValueMeaning":{"publicId":"2945783","version":"1","preferredName":"Nasal Congestion","longName":"2945783","preferredDefinition":"The blockage of the nasal passage due to mucosal edema. It is usually the result of a viral infection or an allergic reaction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nasal Congestion","conceptCode":"C78500","definition":"The blockage of the nasal passage due to mucosal edema. It is usually the result of a viral infection or an allergic reaction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7458E815-91FC-DD76-E040-BB89AD43104A","latestVersionIndicator":"Yes","beginDate":"2009-09-24","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED69-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Nausea prophylaxis","valueDescription":null,"ValueMeaning":{"publicId":"14634882","version":"1","preferredName":"Nausea Preventive Intervention","longName":"14634882v1.00","preferredDefinition":"Upper abdominal discomfort associated with an urge to vomit._Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nausea","conceptCode":"C3258","definition":"Upper abdominal discomfort associated with an urge to vomit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Preventive Intervention","conceptCode":"C15843","definition":"Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECE8-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED6A-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Nausea treatment","valueDescription":null,"ValueMeaning":{"publicId":"14634883","version":"1","preferredName":"Nausea Therapeutic Procedure","longName":"14634883v1.00","preferredDefinition":"Upper abdominal discomfort associated with an urge to vomit._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nausea","conceptCode":"C3258","definition":"Upper abdominal discomfort associated with an urge to vomit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6438D3-ECE9-449C-E063-731AD00A1FE0","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED6B-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Neck pain","valueDescription":null,"ValueMeaning":{"publicId":"2945778","version":"1","preferredName":"Neck Pain","longName":"2945778","preferredDefinition":"Painful sensation in the neck area.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neck Pain","conceptCode":"C50663","definition":"Painful sensation in the neck area.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7458E815-918E-DD76-E040-BB89AD43104A","latestVersionIndicator":"Yes","beginDate":"2009-09-24","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED6C-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Neuralgia/nerve pain","valueDescription":null,"ValueMeaning":{"publicId":"2945774","version":"1","preferredName":"Neuralgia","longName":"2945774","preferredDefinition":"Intense painful sensation along a nerve or group of nerves. It is caused by irritation or trauma to a nerve or inflammation of a nerve.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuralgia","conceptCode":"C79695","definition":"Intense painful sensation along a nerve or group of nerves. It is caused by irritation or trauma to a nerve or inflammation of a nerve.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7458E815-9142-DD76-E040-BB89AD43104A","latestVersionIndicator":"Yes","beginDate":"2009-09-24","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED6D-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Obstruction","valueDescription":null,"ValueMeaning":{"publicId":"4394905","version":"1","preferredName":"Obstruction","longName":"4394905","preferredDefinition":"Blockage of a passageway.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Obstruction","conceptCode":"C3284","definition":"Blockage of the normal flow of the contents of an anatomical passageway.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB5698F-CC25-FBDD-E040-BB89AD431F32","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B6438D3-ED6E-449C-E063-731AD00A1FE0","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Chest pain - cardiac","valueDescription":null,"ValueMeaning":{"publicId":"14635865","version":"1","preferredName":"Cardiac Chest Pain","longName":"14635865v1.00","preferredDefinition":"Having to do with the heart._Pain in the chest.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cardiac","conceptCode":"C13306","definition":"Having to do with the heart.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Chest Pain","conceptCode":"C38665","definition":"Pain in the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B645356-3DA3-488D-E063-731AD00ACBFE","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B645356-3DA4-488D-E063-731AD00ACBFE","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"},{"value":"Appetite stimulant","valueDescription":null,"ValueMeaning":{"publicId":"14635866","version":"1","preferredName":"Appetite stimulant","longName":"14635866v1.00","preferredDefinition":"Appetite stimulant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B645951-AC0D-49CF-E063-731AD00AA84E","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B645951-AC0E-49CF-E063-731AD00AA84E","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"14634417","version":"1","preferredName":"Concomitant Agent Reason","preferredDefinition":"A pharmaceutical agent other than agent(s) tested in a given protocol that is administered to or used by a subject either prior to or during the study. Supportive care and essential ancillary medications required by a treatment regimen should be clearly identified. A protocol's complete instructions including appropriate indication, dosage, administration route, schedule, restrictions to use, and any other relevant data should be explicitly stated. Concept also refers to substance(s) used prior or during the study that are not specified by the protocol._An explanation of the cause of some phenomenon or action.","longName":"14634417v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Concomitant Agent","conceptCode":"C70902","definition":"A pharmaceutical agent other than agent(s) tested in a given protocol that is administered to or used by a subject either prior to or during the study. Supportive care and essential ancillary medications required by a treatment regimen should be clearly identified. A protocol's complete instructions including appropriate indication, dosage, administration route, schedule, restrictions to use, and any other relevant data should be explicitly stated. Concept also refers to substance(s) used prior or during the study that are not specified by the protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B638911-7456-1549-E063-731AD00AE1BB","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2023-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B638911-7457-1549-E063-731AD00AE1BB","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeDescription":null,"administrativeNotes":"1/10/23 Released for CCTG cjl;11/30/23 Created VD for CCTG ticket number CADSR0003135 cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"CM_CMINDC","type":"OID, CCTG","context":"CCTG"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"What is the reason the concomitant medication was administered?","url":null,"context":"CCTG"},{"name":"CCTG_01","type":"Alternate Question Text","description":"Indication","url":null,"context":"CCTG"}],"origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B6398ED-2774-18B9-E063-731AD00ADB4A","latestVersionIndicator":"Yes","beginDate":"2023-11-30","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-30","modifiedBy":"CLOHNES","dateModified":"2024-01-10","changeDescription":null,"administrativeNotes":"1/10/23 Released for CCTG cjl;11/30/23 Created CDE for CCTG ticket number CADSR0003135 cjl.","unresolvedIssues":null,"deletedIndicator":"No"}}